[Superficial bladder cancer with lung metastasis without local invasion: a case report].
A 66-year-old woman presented with a coin-size lesion in the right lung. Bronchoalveolar lavage cytology showed class V. Thoracoscopic partial pneumonectomy of right upper lobe was performed and pathologic finding was metastatic transitional cell carcinoma (TCC). She had a history of superficial bladder tumors which were treated with transurethral resection (TURBT). All pathologic findings demonstrated low grade superficial TCC. After the pneumonectomy, recurrent tumors were detected in the bladder after three months' follow up. Intravesical instillations and TURBT were performed and the pathologic finding showed superficial TCC. There have been no signs of recurrence during the six-year follow up. The case reported here is of superficial cancer with a metastatic lesion in the lung without local invasion in the urinary bladder.
Hirayama
Takahiro
T
Department of Urology, Kitasato University School of Medicine.
Matsumoto
Kazumasa
K
Irie
Akira
A
Iwamura
Masatsugu
M
Kudoh
Osamu
O
Iwabuchi
Keiichi
K
Ao
Teruaki
T
Uchida
Toyoaki
T
Baba
Shiro
S
D000283:Administration, Intravesical; D000284:Administration, Oral; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001500:BCG Vaccine / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D003131:Combined Modality Therapy; D015653:Cystectomy; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D011013:Pneumonectomy / Q000379:methods; D005641:Tegafur / Q000008:administration & dosage; D013906:Thoracoscopy; D014498:Uracil / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D004338:Drug Combinations; D007166:Immunosuppressive Agents; C096910:UFT(R) drug; D005641:Tegafur; D014498:Uracil; D004317:Doxorubicin; C027260:pirarubicin